CrossAmerica Partners (CAPL) Misses Q2 EPS by 6c

CrossAmerica Partners (NYSE: CAPL) reported Q2 EPS of ($0.01), $0.06 worse than the analyst estimate of $0.05. Revenue for the quarter came in at $647.45 million versus the consensus estimate of $618.83 million.

For earnings history and earnings-related data on CrossAmerica Partners (CAPL) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c